Quantcast

Today's Transactions:
Perrigo Buys Pet Medication Co. for $160M

The target, Velcera, makes PetArmor flea and tick preventive medicine

Perrigo Co. (Nasdaq: PRGO) will acquire Velcera, a company that makes animal health products, for $160 million in cash.

Yardley, Pa.-based Velcera offers pet health products through its FidoPharm subsidiary, including PetArmor flea and tick preventive medicine, and other products.

Perrigo makes prescription and over-the-counter medication. In December, the company closed a deal for Cobrek Pharmaceuticals Inc. for $45 million.  The company, headquartered in Allegan, Mich., develops Aller-Ease, Nicotine Gum and Clear Lax.

Morgan Lewis & Bockius LLP served as legal counsel to Perrigo on the deal.

In September, Bayer AG agreed to buy Teva Pharmaceutical Industries Ltd.'s (NYSE: TEVA)'s health business for $145 million. 

 

For more information on related topics, visit the following: